Boston Scientific cyberattack disrupts guidance despite demand holding up
A cyberattack disrupted Boston Scientific’s guidance despite no reported shortfall in demand or device performance. The setup shifts attention from operating momentum to the duration, cost and disclosure risk of the incident.
The story
Boston Scientific experienced a cyberattack that disrupted its guidance, though underlying demand and device performance remained intact. The attack's affected systems, duration and financial impact remain unclear, as does whether the company withdrew, delayed or revised specific outlook measures.
The contrast lies between intact underlying demand and a guidance problem caused by the attack. Without prior guidance figures, outage timeline or comparison with an earlier forecast, the change in the outlook cannot be quantified.
For Boston Scientific, the direct operational links are evident: an attack could affect order processing, manufacturing, logistics, billing or the company's ability to prepare financial forecasts. The company's FY 2025 revenue was $20.1B, up 19.9% year over year, with a 69.0% gross margin and 14.4% net margin; those figures provide scale but do not establish the incident's current-quarter effect.
Key questions remain about the attack's scope, whether demand remained intact across all device categories, and whether any costs, remediation charges or customer impacts are expected.
The next critical disclosures will be the company's formal update on systems and operations, any revised guidance, and the next earnings release. The key figures will be the duration of disruption, any change to revenue or EPS guidance, incremental remediation costs and evidence of delayed shipments or procedures.
Our read · Sun, Sep 13
The cyberattack keeps BSX’s demand story intact but moves the near-term risk toward guidance reliability and disruption costs.
Why. The immediate implication is a split read: Boston Scientific's demand and device performance show operational momentum, while the cyberattack creates an unquantified risk to forecasting, execution and incident costs. BSX's FY 2025 revenue growth of 19.9% offers trajectory support, but the disruption's ability to affect that momentum remains uncertain.
Both cases
What could change this view: A formal update showing no material operational or financial impact would remove the principal downside, while evidence of shipment delays, remediation costs or withdrawn guidance would deepen it.
Who reported it · 1
Keep reading
More on BSX
Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.Boston Scientific reports cybersecurity incident affecting operations, shares fallLatest on the Wire
Greer says US chip curbs will close China export-control loopholesBlackRock bitcoin ETF posts $541.1 million outflow as tech sell-off spreadsPoland says Russian missiles and drone crashed during Ukraine assaultAnthropic debut fails to halt technology-led slide in US stocksUS MATCH Act puts ASML at center of China chip export disputeContinue on the Wire →Latest on the Wire
Beijing plans to bar young red-chip firms from overseas listingsGerman producer prices jump 8.1% in October as industrial inflation acceleratesChina seeks protections to restart US private-equity investmentsAMD shares fall 11% after Hunterbrook warns over China linksContinue on the Wire →Top this week
Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookAnthropic Said to Guide IPO Pricing Above Market RangeNvidia interim CEO Colette Kress faces first earnings test after HuangAnthropic IPO could become the largest in US history on ThursdayAbout this report
Reported by Yahoo Finance as Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.
, . Who answers for this
The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
